GSK vs LAUR · P/E 13, $103.31B cap vs P/E 13, rev $888.5M
GlaxoSmithKline PLC ADR (GSK) versus Laureate Education Inc (LAUR) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Laureate Education Inc (LAUR) is a education & training services company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported LAUR revenue for 2026-06-30 was $888.5M. Net income was $115.5M. LAUR currently screens at market cap $3.52B and trailing P/E 12.7.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. LAUR currently screens at market cap $3.52B and trailing P/E 12.7.
Not investment advice. Open the GSK and LAUR stock pages for the full models.
Not investment advice.